FDA Patent Listing Review System Suggested By Paxil Appeals Court
An FDA system to review patents for Orange Book listing would be feasible, U.S. Federal Circuit Judge Jay Plager suggested Feb. 4
An FDA system to review patents for Orange Book listing would be feasible, U.S. Federal Circuit Judge Jay Plager suggested Feb. 4